{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:47:45Z","timestamp":1765608465076},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejphar.2015.04.004","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T23:45:06Z","timestamp":1429314306000},"page":"36-41","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Des-aspartate-angiotensin I, a novel angiotensin AT1 receptor drug"],"prefix":"10.1016","volume":"760","author":[{"given":"Meng-Kwoon","family":"Sim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.04.004_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/187153006779025711","article-title":"Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy","volume":"6","author":"Akaogi","year":"2006","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.ejphar.2015.04.004_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejphar.2012.02.032","article-title":"Des-aspartate-angiotensin I exerts antiviral effects and attenuates ICAM-1 formation in rhinovirus-infected epithelial cells","volume":"683","author":"Ang","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib3","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1111\/j.1476-5381.1995.tb15943.x","article-title":"Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils","volume":"116","author":"Armstrong","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bjp.0703149","article-title":"Peroxisome proliferator-activated receptors in the cardiovascular system","volume":"129","author":"Bishop-Bailey","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/jcem-32-4-575","article-title":"The effect of heptapeptide (2\u20138) fragments of angiotensin II on aldosterone secretion","volume":"32","author":"Blair-West","year":"1971","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2015.04.004_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1210\/endo-100-1-46","article-title":"(Des-asp1)angiotensin I: a study of its pressor and steroidogenic activities in conscious rats","volume":"100","author":"Campbell","year":"1977","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2015.04.004_bib7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.peptides.2004.06.009","article-title":"Transport of angiotensin peptides across caco-2 monolayer","volume":"24","author":"Chua","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2015.04.004_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrneph.2012.42","article-title":"Proteinuria should be used as a surrogate in CKD","volume":"8","author":"Cravedi","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0090-6980(01)00131-9","article-title":"Novel mode of action of iloprost: in vitro down-regulation of endothelial cell adhesion molecules","volume":"65","author":"Della Bella","year":"2001","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2015.04.004_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.HYP.28.1.104","article-title":"Angiotensin-(1\u20137) inhibits vascular smooth muscle cell growth","volume":"28","author":"Freeman","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2015.04.004_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","article-title":"The intrarenal renin-angiotensin system: form physiology to pathobiology of hypertension and kidney disease","volume":"59","author":"Kobori","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2015.04.004_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1210\/jcem-50-1-40","article-title":"Biological activity of des-asp1-angiotensin I in man","volume":"50","author":"Kono","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2015.04.004_bib13","first-page":"72","article-title":"Blood volume in the rat","volume":"25","author":"Lee","year":"1985","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejphar.2015.04.004_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/10739680701829802","article-title":"Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice","volume":"15","author":"Lee","year":"2008","journal-title":"Microcirculation"},{"key":"10.1016\/j.ejphar.2015.04.004_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/bj2270337","article-title":"The effect of prostaglandins E1, E2 and F2\u03b1 and indomethacin on the sensitivity of glycolysis and glycogen synthesis to insulin in stripped soleus muscle of the rat","volume":"227","author":"Leighton","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2015.04.004_bib16","first-page":"89","article-title":"Role of prostaglandins as modulators of insulin-stimulated glucose metabolism in skeletal muscle","volume":"22","author":"Leighton","year":"1990","journal-title":"Horm. Metab. Res. Suppl."},{"key":"10.1016\/j.ejphar.2015.04.004_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0167-0115(00)00162-2","article-title":"Effects of des-aspartate-angiotensin I on angiotensin II-induced incorporation of phenylalanine and thymidine in cultured rat cardiomyocytes and aortic smooth muscle cells","volume":"95","author":"Min","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2015.04.004_bib18","first-page":"321","article-title":"Experimentally induced chronic renal insufficiency in the rat","volume":"11","author":"Morrison","year":"1962","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ejphar.2015.04.004_bib19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jat.1599","article-title":"Protective actions of des-aspartate-angiotensin I in mice model of CESS-induced lung intoxication","volume":"31","author":"Ng","year":"2011","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1007110304044","article-title":"Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2\/EP4 receptors by prostaglandin E2 in human fibroblast","volume":"25","author":"Noguchi","year":"2001","journal-title":"Inflammation"},{"key":"10.1016\/j.ejphar.2015.04.004_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1399-302x.2000.150505.x","article-title":"Prostaglandins E2 and I2 downregulate tumor necrosis factor \u03b1-induced intercellular adhesion molecule-1 expression in human oral gingival epithelial cells","volume":"15","author":"Noguchi","year":"2000","journal-title":"Oral Microbiol. Immunol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0024-3205(95)02050-S","article-title":"PGI2 analogue, sodium beraprost, suppresses superoxide generation in human neutrophils by inhibiting p47Phox phosphorylation","volume":"57","author":"Okuyama","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2015.04.004_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/diacare.18.2.200","article-title":"Low-dose iloprost infusion improves insulin action in aged healthy subject and NiDDM patients","volume":"18","author":"Paolisso","year":"1995","journal-title":"Diabet. Care"},{"key":"10.1016\/j.ejphar.2015.04.004_bib200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0014-2999(95)00686-9","article-title":"Actions of D-amino acid-substituted analogues of des-Asp-angiotensin I on the central pressor action of angiotensin III","volume":"294","author":"Radhakrishnan","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib24","doi-asserted-by":"crossref","first-page":"H218","DOI":"10.1152\/ajpheart.1979.237.2.H218","article-title":"Formation of angiotensin III from [des-asp1]angiotensin I in the mesenteric vasculature","volume":"6","author":"Sexton","year":"1979","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"10.1016\/j.ejphar.2015.04.004_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/08037059409102267","article-title":"Formation of des-Asp-angiotensin I in the hypothalamic extract of normo- and hypertensive rats","volume":"3","author":"Sim","year":"1994","journal-title":"Blood. Press."},{"key":"10.1016\/j.ejphar.2015.04.004_bib26","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/0006-2952(93)90054-Z","article-title":"Degradation of angiotensin I in the endothelium and smooth muscle of the rat aorta","volume":"45","author":"Sim","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib27","unstructured":"Sim, M.K., 2011. Use of des-aspartate-angiotensin I. United States Patent US7,981,867 B2."},{"key":"10.1016\/j.ejphar.2015.04.004_bib28","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1476-5381.1996.tb15313.x","article-title":"Subtypes of losartan-sensitive in the rabbit pulmonary artery","volume":"117","author":"Sim","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0006-2952(94)90376-X","article-title":"Degradation of angiotensin I to [des-Asp1]angiotensin I by a novel aminopeptidase in the rat hypothalamus","volume":"48","author":"Sim","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0167-5273(97)00324-0","article-title":"Effects of des-Asp-angiotensin I on experimentally-induced cardiac hypertrophy in rats","volume":"63","author":"Sim","year":"1998","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0167-0115(02)00289-6","article-title":"Angiotensin in plasma of hypertensive rats and human","volume":"111","author":"Sim","year":"2003","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2015.04.004_bib32","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0014-2999(94)90714-5","article-title":"Novel central action of des-Asp-angiotensin I","volume":"257","author":"Sim","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib33","unstructured":"Sim, M.K., Tan, C.C., 2009. Use of des-aspartate-angiotensin I as an agent for the treatment and prevention of glomerulosclerosis and renal failure. United State Patent US7,553,828 B2."},{"key":"10.1016\/j.ejphar.2015.04.004_bib34","first-page":"213","article-title":"Effects of des-aspartate-angiotensin I on neointima growth and cardiovascular hypertrophy","volume":"17","author":"Sim","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2015.04.004_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.regpep.2013.12.003","article-title":"Des-aspartate-angiotensin I attenuates ICAM-1 formation in hydrogen peroxide-treated L6 skeletal muscle cells and soleus muscle of mice subjected to eccentric exercise","volume":"188","author":"Sim","year":"2014","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2015.04.004_bib36","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/en.2007-0606","article-title":"Des-aspartate-angiotensin I exerts hypoglycemic action via glucose transporter-4 translocation in type 2 diabetic KKAy mice and GK rats","volume":"148","author":"Sim","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2015.04.004_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000414783","article-title":"Animal models to induce renal failure: a historical survey","volume":"60","author":"Strauch","year":"1988","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.HYP.33.1.207","article-title":"Angiotensin-(1\u20137) reduces smooth muscle growth after vascular injury","volume":"33","author":"Strawn","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2015.04.004_bib39","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.4049\/jimmunol.168.9.4446","article-title":"Prostaglandin E2 inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2\/EP4 receptors in human peripheral blood mononuclear cells","volume":"168","author":"Takahashi","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib40","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1476-5381.1995.tb13370.x","article-title":"Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils","volume":"114","author":"Talpain","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/jm00246a002","article-title":"Synthesis and evaluation of [des-asp1]angiotensin I as a precursor of [des-asp1]angiotensin II (\u201cangiotensin III\u201d)","volume":"18","author":"Tsai","year":"1979","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.04.004_bib42","first-page":"194","article-title":"Pressor and steroidogenic actions of [des-Asp1] angiotensin I dependency on conversion to angiotensin III","volume":"40","author":"Vaughan","year":"1977","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2015.04.004_bib43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF00571947","article-title":"Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanism of insulin action","volume":"31","author":"Wasner","year":"1994","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2011.02.014","article-title":"Effects of des-aspartate-angiotensin I on myocardial ischemia\u2013reperfusion injury in rats","volume":"658","author":"Wen","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.regpep.2004.03.003","article-title":"Reduction of infarct size by orally administered des-aspartate-angiotensin I in the ischemic reperfused rat heart","volume":"120","author":"Wen","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2015.04.004_bib46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bcp.2011.07.080","article-title":"Des-aspartate-angiotensin I and angiotensin IV improve glucose tolerance and insulin signaling in diet-induce hyperglycaemic mice","volume":"82","author":"Wong","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.004_bib47","first-page":"S408","article-title":"Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats","volume":"4","author":"Wright","year":"1986","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2015.04.004_bib48","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.178.2.702","article-title":"Prostaglandins I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dentritic cells","volume":"178","author":"Zhou","year":"2007","journal-title":"J. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915003258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915003258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T15:03:53Z","timestamp":1566572633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915003258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":49,"alternative-id":["S0014299915003258"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.004","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Des-aspartate-angiotensin I, a novel angiotensin AT1 receptor drug","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}